S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
ASX:ALX

Atlas Arteria Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3.69 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield4.15%
BetaN/A

Receive ALX News and Ratings via Email

Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter.


About Atlas Arteria

Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Infrastructure Operations
Sub-Industry
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$106.65 million
Book Value
A$3.74 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.57 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Atlas Arteria (ASX:ALX) Frequently Asked Questions

What stocks does MarketBeat like better than Atlas Arteria?

Wall Street analysts have given Atlas Arteria a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Atlas Arteria wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Atlas Arteria pay dividends? What is the dividend yield for Atlas Arteria?

Atlas Arteria announced a Interim dividend on Wednesday, September 22nd. Investors of record on Monday, October 4th will be given a dividend of 0.155 per share on Monday, October 4th. This represents a dividend yield of 2.27%. The ex-dividend date of this dividend is Thursday, September 23rd. This is an increase from Atlas Arteria's previous Interim dividend of A$0.11.
View Atlas Arteria's dividend history
.

Is Atlas Arteria a good dividend stock?

Atlas Arteria pays an annual dividend of A$0.26 per share and currently has a dividend yield of 4.15%. ALX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Atlas Arteria's dividend history.

Who are Atlas Arteria's key executives?

Atlas Arteria's management team includes the following people:
  • Mr. Graeme Francis Bevans, MD, CEO & Exec. Director (Age 63, Pay $1.91M)
  • Ms. Nadine Lennie, Chief Financial Officer (Age 48, Pay $990.75k)
  • Mr. Vincent Portal-Barrault, Chief Operating Officer
  • Jeanette Royce, Director of Investor Relations
  • Mr. Clayton John McCormack BCom, LLB, Company Sec. & Gen. Counsel
  • Navleen Prasad, Public Affairs Mang.

What other stocks do shareholders of Atlas Arteria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atlas Arteria investors own include Transurban Group (TCL), Sydney Airport (SYD), Macquarie Atlas Roads Group (MQA) and Inghams Group (ING).

What is Atlas Arteria's stock symbol?

Atlas Arteria trades on the ASX under the ticker symbol "ALX."

How much money does Atlas Arteria make?

Atlas Arteria has a market capitalization of $0.00 and generates $106.65 million in revenue each year.

How many employees does Atlas Arteria have?

Atlas Arteria employs 70 workers across the globe.

What is Atlas Arteria's official website?

The official website for Atlas Arteria is www.atlasarteria.com.

Where are Atlas Arteria's headquarters?

Atlas Arteria is headquartered at 210 Route 4 East, Paramus, New Jersey 07652.

How can I contact Atlas Arteria?

Atlas Arteria's mailing address is 210 Route 4 East, Paramus, New Jersey 07652. The company can be reached via phone at 61 2 8232 7455.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.